Our recent findings reveal that CAFs from platinum-resistant patients notably enhance oxaliplatin resistance in pancreatic cancer cells by secreting IL-8 and extracellular vesicles, facilitating a non-homologous end joining (NHEJ) dependent DNA repair mechanism [15]. This evidence concerns the gene CXCL8 and pancreatic neoplasm.